Beta blockers and verapamil: a cautionary tale.
作者信息
Hutchison S J, Lorimer A R, Lakhdar A, McAlpine S G
出版信息
Br Med J (Clin Res Ed). 1984 Sep 15;289(6446):659-60. doi: 10.1136/bmj.289.6446.659-a.
Abstract
摘要
相似文献
1
Beta blockers and verapamil: a cautionary tale.β受体阻滞剂与维拉帕米：一则警示故事。
Br Med J (Clin Res Ed). 1984 Sep 15;289(6446):659-60. doi: 10.1136/bmj.289.6446.659-a.
2
Beta blockers and verapamil: a cautionary tale.β受体阻滞剂与维拉帕米：一则警示故事。
Br Med J (Clin Res Ed). 1984 Dec 8;289(6458):1624. doi: 10.1136/bmj.289.6458.1624-b.
3
Sinus arrest caused by atenolol-verapamil combination.阿替洛尔-维拉帕米联用引起的窦性停搏。
Clin Cardiol. 1987 Jun;10(6):365-7. doi: 10.1002/clc.4960100613.
4
Probable adverse interaction between oral metoprolol and verapamil.口服美托洛尔与维拉帕米之间可能存在不良相互作用。
Postgrad Med J. 1984 Oct;60(708):705-6. doi: 10.1136/pgmj.60.708.705.
5
[A-V block secondary to cimetidine-verapamil interaction].[西咪替丁与维拉帕米相互作用继发的房室传导阻滞]
Harefuah. 1987 Aug;113(3-4):67.
6
[Atrioventricular complete heart block developed due to verapamil use together with honey consumption].[因同时使用维拉帕米和食用蜂蜜而发生房室完全性心脏传导阻滞]
Anadolu Kardiyol Derg. 2003 Dec;3(4):353-4.
7
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.在降低既往心肌梗死患者心血管事件方面，基于维拉帕米缓释片的治疗策略等同于基于阿替洛尔的治疗策略：一项国际维拉帕米缓释片-群多普利（INVEST）子研究。
Am Heart J. 2008 Aug;156(2):241-7. doi: 10.1016/j.ahj.2008.02.023.
8
Refractory cardiogenic shock and complete heart block after verapamil SR and metoprolol treatment. A case report.
Angiology. 1995 Jun;46(6):517-9. doi: 10.1177/000331979504600609.
9
A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).国际维拉帕米缓释片-群多普利研究（INVEST）中钙拮抗剂与阿替洛尔高血压治疗策略治疗患者的抗高血压药物与抑郁症状研究（SADD-Sx）
Psychosom Med. 2005 May-Jun;67(3):398-406. doi: 10.1097/01.psy.0000160468.69451.7f.
10
Identifying iatrogenic depression using confirmatory factor analysis of the Center for Epidemiologic Studies Depression Scale in patients prescribed a verapamil-sustained-release-led or atenolol-led hypertension treatment strategy.使用验证性因子分析方法分析接受维拉帕米缓释片或阿替洛尔主导的高血压治疗策略的患者的流行病学研究抑郁量表（Center for Epidemiologic Studies Depression Scale），以确定医源性抑郁。
Res Social Adm Pharm. 2012 Jul-Aug;8(4):309-20. doi: 10.1016/j.sapharm.2011.08.002. Epub 2011 Dec 1.
引用本文的文献
1
Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.卡替洛尔滴眼液与维拉帕米联合应用致老年心房颤动并慢性肾脏病患者心动过缓性休克
Intern Med. 2021 Jan 1;60(1):79-83. doi: 10.2169/internalmedicine.5598-20. Epub 2020 Aug 22.
2
Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.维拉帕米：其药理特性及在冠状动脉疾病中的治疗应用综述
Drugs. 1996 May;51(5):792-819. doi: 10.2165/00003495-199651050-00007.
3
A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris.维拉帕米、阿替洛尔及其联合用药治疗慢性稳定型心绞痛患者的双盲安慰剂对照比较
Br Heart J. 1987 Apr;57(4):336-43. doi: 10.1136/hrt.57.4.336.
4
The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction.口服硝苯地平与普萘洛尔单独及联合应用对高血压患者的影响，特别涉及房室传导
Br J Clin Pharmacol. 1986 Oct;22(4):463-7. doi: 10.1111/j.1365-2125.1986.tb02918.x.
5
Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man.口服阿替洛尔与维拉帕米在人体中的相互作用程度及药代动力学机制。
Eur J Clin Pharmacol. 1988;35(4):363-6. doi: 10.1007/BF00561365.
6
Severe bradycardia due to interaction of timolol eye drops and verapamil.噻吗洛尔滴眼液与维拉帕米相互作用导致严重心动过缓。
Br Med J (Clin Res Ed). 1987 Jan 17;294(6565):155-6. doi: 10.1136/bmj.294.6565.155-a.
7
Adverse reactions and interactions with beta-adrenoceptor blocking drugs.β-肾上腺素能受体阻断药的不良反应及相互作用。
Med Toxicol. 1986 Sep-Oct;1(5):343-61. doi: 10.1007/BF03259848.
8
Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.维拉帕米。对其药效学和药代动力学特性以及在高血压治疗中的应用的最新综述。
Drugs. 1989 Jul;38(1):19-76. doi: 10.2165/00003495-198938010-00003.
9
Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.钙通道拮抗与β受体阻滞剂联合应用——心血管疾病的一种治疗选择。综述
Cardiovasc Drugs Ther. 1989 Jun;3(3):355-73. doi: 10.1007/BF01858108.
Zotero 插件